Contract awardedUnlicensed medicines
DHA tablets for Miscarriage MAMS trial, 28 capsules per pack
- University of Birmingham
- West Midlands
- Direct award
- 21 January 2025 to 25 April 2025
Provision of DHA tablets packaged in 28-capsule units for the Miscarriage MAMS clinical trial. This is a specific supply contract for pharmaceutical products required to support ongoing medical research protocols.
- Awarded value
- £62k
- As published
- Published
- 29 July 2026
- Contract length
- 3 months
- Ends 25 April 2025